The FDA in the US has granted clearance to BrainStorm to commence a Phase IIIb trial of its NurOwn therapy for ALS.

Peptidomimetics are synthetic analogs that retain the essential structure and function of peptides but with chemical ...

In a story of resilience and hope, the Weber family stands as a reminder of the impact of familial bonds in the face of ...

BrainStorm Cell Therapeutics saw rising retail chatter Monday when it obtained FDA clearance for Phase 3b clinical trials of ...

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...

Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...

Ninth-grade students from the Massapequa High School Ames Campus made an encouraging donation and celebrated those with the ...